Contents:

- Introducing the Market Engineering Consulting Report - The Market Engineering System - Market Engineering Report Elements - Strategic Benefits of Market Engineering for Readers of This Report - A Word of Caution - Executive Summary - Introduction to the Asthma and Rhinitis Therapeutic Products Market - Summary of Major Findings - Industry Challenges and Research Methodology - Identification of Challenges Facing the Asthma and Rhinitis Therapeutic Products Market - Time Frame Analysis of Industry Challenges - Frost & Sullivan's 12-Step Market Engineering Research Methodology - Market Engineering Forecasting Methodology - Glossary of Terms - Market Engineering Research for the Total European Asthma and Rhinitis Therapeutic Products Market - Strategic Analysis and Forecasts of the Total Market - Presentation of Strategic Significance of Measurements - Strategic Analysis and Forecasts of the Anti-Inflammatory Agents and Mast Cell Mediators Market - Strategic Analysis and Forecasts of the Bronchodilators Market - Strategic Analysis and Forecasts of the Methylxanthines Market - Strategic Analysis and Forecasts of the Total Antihistamines Market - Innovative Therapeutic Approaches in the Pipeline to Treat Asthma and Rhinitis - Market Engineering Research for the German Asthma and Rhinitis Therapeutic Products Market - Strategic Analysis and Forecasts of the Total Market - Strategic Analysis and Forecasts of the German Anti-Inflammatory Agents and Mast Cell Mediators Market - Strategic Analysis and Forecasts of the German Bronchodilators Market - Strategic Analysis and Forecasts of the German Methylxanthines Market - Strategic Analysis and Forecasts of the German Antihistamines Market - Market Engineering Research for the French Asthma and Rhinitis Therapeutic Products Market - Strategic Analysis and Forecasts of the Total Market - Strategic Analysis and Forecasts of the French Anti-Inflammatory Agents and Mast Cell Mediators Market - Strategic Analysis and Forecasts of the French Bronchodilators Market - Strategic Analysis and Forecasts of the French Methylxanthines Market - Strategic Analysis and Forecasts of the French Antihistamines Market - Market Engineering Research for the United Kingdom Asthma and Rhinitis Therapeutic Products Market - Strategic Analysis and Forecasts of the Total Market - Strategic Analysis and Forecasts of the United Kingdom Anti-Inflammatory Agents Market - Strategic Analysis and Forecasts of the United Kingdom Bronchodilators Market - Strategic Analysis and Forecasts of the United Kingdom Methylxanthines Market - Strategic Analysis and Forecasts of the United Kingdom Antihistamines Market - Market Engineering Research for the Italian Asthma and Rhinitis Therapeutic Products Market - Strategic Analysis and Forecasts of the Total Market - Strategic Analysis and Forecasts of the ItalianAnti-Inflammatory Agents and Mast Cell Mediators Market - Strategic Analysis and Forecasts of the Italian Bronchodilators Market - Strategic Analysis and Forecasts of the Italian Methylxanthines Market - Strategic Analysis and Forecasts of the Italian Antihistamines Market - Market Engineering Research for the Spanish Asthma and Rhinitis Therapeutic Products Market - Strategic Analysis and Forecasts of the Total Market - Strategic Analysis and Forecasts of the Spanish Anti-Inflammatory Agents and Mast Cell Mediators Market - Strategic Analysis and Forecasts of the Spanish Bronchodilators Market - Strategic Analysis and Forecasts of the Spanish Methylxanthines Market - Strategic Analysis and Forecasts of the Spanish Antihistamines Market - Market Engineering Research for the Belgian and Netherlands Asthma and Rhinitis Therapeutic Products Market - Strategic Analysis and Forecasts of the Total Market - Strategic Analysis and Forecasts of the Belgian and Netherlands Anti-Inflammatory Agents and Mast Cell Mediators Market - Strategic Analysis and Forecasts of the Belgian and Netherlands Bronchodilators Market - Strategic Analysis and Forecasts of the Belgian and Netherlands Methylxanthines Market - Strategic Analysis and Forecasts of the Belgian and Netherlands Antihistamines Market - Market Engineering Research for the Scandinavian Asthma and Rhinitis Therapeutic Products Market - Strategic Analysis and Forecasts of the Total Market - Strategic Analysis and Forecasts of the Scandinavian Anti-Inflammatory Agents and Mast Cell Mediators Market - Strategic Analysis and Forecasts of the Scandinavian Bronchodilators Market - Strategic Analysis and Forecasts of the Scandinavian Methylxanthines Market - Strategic Analysis and Forecasts of the Scandinavian Antihistamines Market - Market Engineering Research for the Rest-of-Europe Asthma and Rhinitis Therapeutic Products Market - Strategic Analysis and Forecasts of the Total Market - Strategic Analysis and Forecasts of the Rest-of-Europe Anti-Inflammatory Agents and Mast Cell Mediators Market - Strategic Analysis and Forecasts of the Rest-of-Europe Bronchodilators Market - Strategic Analysis and Forecasts of the Rest-of-Europe Methylxanthines Market - Strategic Analysis and Forecasts of the Rest-of-Europe Antihistamines Market - Market Engineering Strategy - What Is Market Engineering Strategy? - How to Improve the Market Engineering Strategy Development Process - Market Engineering Strategic Recommendations - Market Engineering Planning in the Asthma and Rhinitis Therapeutic Products Industry - Integrating Market Engineering into the Business Planning Process - Using Market Engineering Planning to Support the Business Planning Process - Implementation of Market Engineering - Introduction and Summary - How to ImplementMarket Engineering in a Company - How to Make the Most of This Market Engineering Report - Market Engineering Monitoring of the Asthma and Rhinitis Therapeutic Products Industry - The Purpose of Market Engineering Monitoring - How to Design a Successful Monitoring Programme - Top Ten Critical Elements of a Market Engineering Programme in the Asthma and Rhinitis Therapeutic Products Industry - Frost & Sullivan's Strategic Recommendations for Further Research - Profiles of Strategically Targeted Companies - 3M Pharmaceuticals (1) (612) 733 1110 - AB Astra (46) 8 5532 6000 - Boehringer Ingelheim KG (49) 6132 770 - Glaxo Wellcome plc (44) 171 4934060 - Hoechst Marion Roussel (49) 69 3057856 - Merck Sharp and Dohme (1) (908) 423 1000 - Novartis (41) 61 696 1111 - Orion Pharma (358) 9 4291 - Rhône-Poulenc Rorer Inc (1) (610) 454 8000 - Schering-Plough Corporation (1) (201) 822 7000 - UCB Pharma Ltd (32) 2 641 1414 - Zeneca Pharmaceuticals (44) 1625 582828 - Database of Key Industry Participants - Table of Figures - Table of Charts